BRANCACCIO JOHN P
Insider CIK 1276551 · CLSP Director · TROV Director · SGYP Director · CTRV Chairman, Director · OKYO Director · ACEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKYO OKYO Pharma Ltd | A Award | 2026-07-21 | 2026-07-23 | 5,000 | $1.48 | $7.4K | 35,201 | SEC↗ |
| OKYO OKYO Pharma Ltd | P Buy | 2026-07-21 | 2026-08-07 | 5,000 | $1.48 | $7.4K | 35,201 | SEC↗ |
| OKYO OKYO Pharma Ltd | P Buy | 2026-07-21 | 2026-08-07 | 5,000 | $1.48 | $7.4K | 35,201 | SEC↗ |
| OKYO OKYO Pharma Ltd | A Award deriv | 2026-06-08 | 2026-06-10 | 6,500 | $1.85 | $12.0K | 138,394 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2024-02-19 | 2024-02-21 | 85,000 | — | $0 | 99,563 | SEC↗ |
| OKYO OKYO Pharma Ltd | P Buy | 2023-09-15 | 2023-09-28 | 16,670 | $1.50 | $25.0K | 16,670 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 223 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 26,800 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 28,858 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 44,734 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 195 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 22,000 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 223 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 530 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2022-06-09 | 2022-06-09 | 755 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2022-03-09 | 2022-03-10 | 26,800 | — | $0 | 125,317 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 22,000 | — | $0 | 98,517 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2021-05-18 | 2021-05-20 | 200,000 | — | $0 | 291,332 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-22 | 2021-03-22 | 3,000 | $10.95 | $32.9K | 12,260 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | P Buy | 2020-12-02 | 2020-12-02 | 7,000 | $1.53 | $10.7K | 7,008 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2020-08-19 | 2020-08-21 | 30,000 | — | $0 | 91,332 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 28,858 | — | $0 | 76,517 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2020-05-14 | 2020-05-18 | 6,993 | $1.43 | $10.0K | 9,260 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2020-04-03 | 2020-04-07 | 60,000 | — | $0 | 61,275 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2019-07-24 | 2019-07-25 | 970 | — | $0 | 1,275 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 44,734 | — | $0 | 47,806 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise deriv | 2018-07-04 | 2018-07-06 | 50,023 | — | $0 | 506,173 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | F Tax w/h | 2018-07-04 | 2018-07-06 | 13,896 | — | $0 | 116,571 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise | 2018-07-04 | 2018-07-06 | 50,023 | $0.50 | $25.0K | 130,467 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | P Buy deriv | 2018-07-03 | 2018-07-03 | 3 | $1000.00 | $3.0K | 3 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | P Buy deriv | 2018-07-03 | 2018-07-03 | 1,725 | $1000.00 | $1.73M | 1,725 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2018-06-16 | 2018-06-19 | 114,750 | — | $0 | 556,196 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2018-06-08 | 2018-06-11 | 10,000 | $0.80 | $8.0K | 53,167 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2018-06-08 | 2018-06-13 | 10,000 | $0.80 | $8.0K | 13,598 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise deriv | 2018-04-02 | 2018-04-02 | 50,000 | — | $0 | 441,446 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise | 2018-04-02 | 2018-04-02 | 50,000 | $0.50 | $25.0K | 76,944 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2018-01-23 | 2018-01-25 | 54,322 | — | $0 | 246,130 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 16,667 | — | $0 | 0 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 16,667 | — | $0 | 43,167 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-10-04 | 2017-10-05 | 38,106 | — | $0 | 191,808 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise deriv | 2017-09-02 | 2017-09-06 | 12,667 | — | $0 | 16,667 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise | 2017-09-02 | 2017-09-06 | 12,667 | — | $0 | 26,500 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2017-06-28 | 2017-06-30 | 14,000 | — | $0 | 481,372 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | D To issuer deriv | 2017-06-28 | 2017-06-30 | 14,000 | — | $0 | 467,372 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2017-06-28 | 2017-06-30 | 62,500 | — | $0 | 481,372 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | P Buy | 2017-05-26 | 2017-05-30 | 6,500 | $3.59 | $23.3K | 30,444 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-01-02 | 2017-01-04 | 16,667 | — | $0 | 16,667 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-01-02 | 2017-01-05 | 12,667 | — | $0 | 29,334 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-01-02 | 2017-01-05 | 16,667 | — | $0 | 16,667 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise deriv | 2016-09-19 | 2016-09-21 | 1,439 | — | $0 | 419,951 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise deriv | 2016-09-19 | 2016-09-21 | 1,079 | — | $0 | 418,872 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise | 2016-09-19 | 2016-09-21 | 1,079 | $4.28 | $4.6K | 22,962 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | S Sale | 2016-09-19 | 2016-09-21 | 2,518 | $5.76 | $14.5K | 20,444 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise | 2016-09-19 | 2016-09-21 | 1,439 | $4.61 | $6.6K | 21,883 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2016-07-19 | 2016-07-20 | 65,000 | — | $0 | 200,656 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2016-06-24 | 2016-06-27 | 62,500 | — | $0 | 421,390 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2016-06-24 | 2016-06-29 | 62,500 | — | $0 | 421,390 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 16,000 | — | $0 | 153,702 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2015-07-24 | 2015-07-28 | 37,000 | — | $0 | 358,890 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2015-03-17 | 2015-03-19 | 16,000 | — | $0 | 137,702 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2014-12-11 | 2014-12-15 | 14,000 | — | $0 | 121,702 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2014-12-06 | 2014-12-09 | 74,500 | — | $0 | 321,890 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2014-12-03 | 2014-12-04 | 38,759 | — | $0 | 135,656 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2014-06-10 | 2014-06-12 | 30,000 | — | $0 | 247,390 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | P Buy | 2014-06-03 | 2014-06-03 | 3,500 | $4.12 | $14.4K | 23,944 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2014-04-03 | 2014-04-04 | 15,000 | — | $0 | 96,897 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2014-03-12 | 2014-03-14 | 21,897 | — | $0 | 81,897 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | P Buy | 2014-03-04 | 2014-03-07 | 4,393 | $1.49 | $6.5K | 6,408 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2014-02-25 | 2014-02-26 | 27,886 | — | $0 | 107,702 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | J Other | 2014-02-18 | 2014-02-20 | 2,015 | — | $0 | 2,015 | SEC↗ |
| NONE ContraVir Pharmaceuticals, | A Award deriv | 2014-01-24 | 2014-01-28 | 30,000 | — | $0 | 60,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-07-12 | 2013-07-16 | 43,948 | — | $0 | 217,390 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-07-12 | 2013-07-17 | 43,948 | — | $0 | 249,071 | SEC↗ |
| TROV TrovaGene Inc. | A Award deriv | 2013-02-14 | 2013-02-21 | 23,525 | — | $0 | 79,816 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 6,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 6,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 6,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 6,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 6,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 17,123 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 75,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 6,000 | — | $0 | 0 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 203,684 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 191,094 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 3,080 | — | $0 | 190,015 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 13,493 | — | $0 | 186,935 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 198,648 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 197,569 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 205,123 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 192,533 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 202,605 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 201,166 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 200,087 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 196,130 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 195,051 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 193,612 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 202,605 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 203,684 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 205,123 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 201,166 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 200,087 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 198,648 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 197,569 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 13,493 | — | $0 | 186,935 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 3,080 | — | $0 | 190,015 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 191,094 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 192,533 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 193,612 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,439 | — | $0 | 195,051 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 1,079 | — | $0 | 196,130 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer | 2013-01-17 | 2013-01-22 | 113,636 | — | $0 | 0 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award | 2013-01-17 | 2013-01-22 | 20,444 | — | $0 | 20,444 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award | 2013-01-17 | 2013-01-22 | 20,444 | — | $0 | 20,444 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2012-08-07 | 2012-08-09 | 28,419 | — | $0 | 173,442 | SEC↗ |
| ACEL Tamir Biotechnology, Inc. | A Award deriv | 2012-07-23 | 2012-07-25 | 375,000 | — | $0 | 375,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2012-03-20 | 2012-03-28 | 15,500 | — | $0 | 145,023 | SEC↗ |
| TROV TrovaGene Inc. | A Award deriv | 2012-02-14 | 2012-03-07 | 66,000 | — | $0 | 337,747 | SEC↗ |
| TROV TrovaGene Inc. | A Award deriv | 2012-01-26 | 2012-02-15 | 56,000 | — | $0 | 271,747 | SEC↗ |